In vivo lineage tracing of tumor cells supports these findings, in a Kras/p53-driven mouse model of pancreatic cancer, where circulating and invading tumor cells exhibit a distinct mesenchymal phenotype [36,55]. The gene discussed is KRAS; the disease is neoplasm.